Severe pelvic organ prolapse. Is there a long-term cure?
Long-term outcome
Mesh
Pelvic organ prolapse
Prolapse recurrence
Sacrocolpopexy
Journal
International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
27
06
2018
accepted:
19
09
2018
pubmed:
27
9
2018
medline:
16
4
2020
entrez:
27
9
2018
Statut:
ppublish
Résumé
Vaginally assisted laparoscopic sacrocolpopexy (VALS) is a combined vaginal and laparoscopic surgical approach that has been described for the treatment of women with a uterus who suffer from severe multicompartmental pelvic organ prolapse (POP). The aim of this study is to evaluate the long-term anatomical and functional outcomes and report the long-term mesh-related complications. This was a single-center prospective study of women with advanced POP who underwent VALS with at least 3 years of follow-up. The primary outcome was "composite surgical success" defined as: (1) no descent of the vaginal apex (point C) more than one-third into the vaginal canal and no anterior or posterior vaginal wall beyond the hymen (Ba and Bp < 0) (anatomical success), (2) no vaginal bulge symptoms and (3) no re-treatment for prolapse recurrence. The median follow-up was 7 years (range 3-10 years) with a composite surgical success rate of 95.7% (90/94). Failures (4.3%) included one (1.1%) case of anatomical recurrence (Bp: +1), one woman (1.1%) reporting vaginal bulge symptoms and two women (2.1%) who underwent a posterior colporrhaphy 6 and 12 months after primary surgery (reoperation rate: 2.1%). Two of 94 patients (2.1%) had been treated for mesh extrusion of the vaginal cuff prior to the follow-up visit. The combined VALS technique can be considered a safe and effective procedure for the treatment of severe POP allowing a long-term anatomical restoration of all compartments with excellent functional outcomes.
Identifiants
pubmed: 30255195
doi: 10.1007/s00192-018-3775-3
pii: 10.1007/s00192-018-3775-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1697-1703Références
Female Pelvic Med Reconstr Surg. 2011 May;17(3):115-9
pubmed: 22453781
Female Pelvic Med Reconstr Surg. 2016 May-Jun;22(3):156-60
pubmed: 26571435
Menopause. 2016 Jul;23(7):765-70
pubmed: 27138745
Int Urogynecol J. 2013 Dec;24(12):2131-44
pubmed: 23778998
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Nov;18(11):1317-24
pubmed: 17333439
Int Urogynecol J. 2015 Nov;26(11):1559-73
pubmed: 25966804
Neurourol Urodyn. 2012 Sep;31(7):1141-4
pubmed: 22508384
JAMA. 2013 May 15;309(19):2016-24
pubmed: 23677313
Am J Obstet Gynecol. 2008 Dec;199(6):610.e1-5
pubmed: 18533115
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Oct;19(10):1415-22
pubmed: 18536861
BJOG. 2005 Aug;112(8):1134-8
pubmed: 16045530
Obstet Gynecol. 1997 Oct;90(4 Pt 2):689-91
pubmed: 11770599
Int Urogynecol J. 2010 Jan;21(1):5-26
pubmed: 19937315
Am J Obstet Gynecol. 2004 Jul;191(1):73-82
pubmed: 15295345
Int Urogynecol J Pelvic Floor Dysfunct. 2001;12(3):178-86
pubmed: 11451006
Int Urogynecol J. 2010 May;21(5):523-8
pubmed: 20013110
Am J Obstet Gynecol. 2001 Feb;184(3):297-302
pubmed: 11228477
Am J Obstet Gynecol. 2004 Nov;191(5):1533-8
pubmed: 15547521
Female Pelvic Med Reconstr Surg. 2016 May-Jun;22(3):151-5
pubmed: 26571429
Int Urogynecol J. 2013 May;24(5):839-45
pubmed: 23076648
Neurourol Urodyn. 2018 Jan;37(1):316-321
pubmed: 28481045
Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004014
pubmed: 23633316
Int Urogynecol J. 2015 Mar;26(3):449-50
pubmed: 25338729
Int Urogynecol J. 2012 May;23(5):527-35
pubmed: 22476543
Ultrasound Obstet Gynecol. 2017 Mar;49(3):404-408
pubmed: 26877210
Obstet Gynecol. 2009 Sep;114(3):600-9
pubmed: 19701041